Key statistics
As of last trade, Mink Therapeutics Inc (INKT:NAQ) traded at 0.75, 31.58% above the 52 week low of 0.57 set on Oct 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.76 |
---|---|
High | 0.77 |
Low | 0.75 |
Bid | 0.75 |
Offer | 0.77 |
Previous close | 0.7501 |
Average volume | 37.04k |
---|---|
Shares outstanding | 39.54m |
Free float | 10.02m |
P/E (TTM) | -- |
Market cap | 29.66m USD |
EPS (TTM) | -0.4891 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 14:46 GMT.
More ▼
- MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report
- MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024
- MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors
- MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors
- MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024
- MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference
- MiNK Reports Second Quarter 2024 Results and Business Update
- MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
- MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement
- MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
More ▼